Biodexa`s Phase 2a Study Of Tolimidone For T1D Approved In Canada
16 Jul 2024 //
GLOBENEWSWIRE
Biodexa Enters Into Agreements to Acquire Worldwide License to Tolimidone
27 Nov 2023 //
GLOBENEWSWIRE
Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I,Adds NASH
20 Oct 2021 //
GLOBENEWSWIRE
Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
09 Mar 2021 //
BUSINESSWIRE
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
09 Mar 2021 //
BUSINESSWIRE
Melior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic
15 Sep 2020 //
BIOSPACE